DE3775387D1 - Zusammensetzungen von katecholischen butanen mit zink. - Google Patents

Zusammensetzungen von katecholischen butanen mit zink.

Info

Publication number
DE3775387D1
DE3775387D1 DE8787907401T DE3775387T DE3775387D1 DE 3775387 D1 DE3775387 D1 DE 3775387D1 DE 8787907401 T DE8787907401 T DE 8787907401T DE 3775387 T DE3775387 T DE 3775387T DE 3775387 D1 DE3775387 D1 DE 3775387D1
Authority
DE
Germany
Prior art keywords
zinc
compositions
catecholic
catecholic butanes
new compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787907401T
Other languages
English (en)
Inventor
T Jordan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3775387D1 publication Critical patent/DE3775387D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787907401T 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink. Expired - Lifetime DE3775387D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/924,620 US4880637A (en) 1985-02-11 1986-10-28 Compositions of catecholic butanes with zinc
PCT/US1987/002868 WO1988003026A1 (en) 1986-10-28 1987-10-27 Compositions of catecholic butanes with zinc

Publications (1)

Publication Number Publication Date
DE3775387D1 true DE3775387D1 (de) 1992-01-30

Family

ID=25450444

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787907401T Expired - Lifetime DE3775387D1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink.

Country Status (8)

Country Link
US (1) US4880637A (de)
EP (1) EP0288534B1 (de)
JP (1) JPH01501794A (de)
KR (1) KR880701556A (de)
AT (1) ATE70449T1 (de)
AU (1) AU616641B2 (de)
DE (1) DE3775387D1 (de)
WO (1) WO1988003026A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501791A (ja) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド 薬理学的に活性な化合物およびそれらの混合物、有機組成物および金属塩類
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
WO1995024894A2 (en) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US6365787B1 (en) 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6787573B2 (en) * 1999-07-02 2004-09-07 Universiteit Utrecht Antiviral therapy
US6214874B1 (en) 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US6608108B2 (en) * 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
EP1631270A4 (de) * 2003-05-20 2007-11-14 Erimos Pharmaceutical Llp Verfahren und zusammensetzungen zur abgabe von catecholischen butanen zur behandlung von krankheiten
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
US7728036B2 (en) 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
CN109134205B (zh) 2004-05-28 2022-07-19 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
ES2606332T3 (es) * 2005-01-27 2017-03-23 Erimos Pharmaceuticals Llc Formulaciones orales para la administración de butanos catecólicos incluyendo compuestos de NDGA
CN101150956B (zh) * 2005-01-27 2013-04-17 埃里莫斯医药品有限公司 用于注射入动物的包括ndga化合物的儿茶酚丁烷配方
JP2009528294A (ja) * 2006-02-23 2009-08-06 エリモス・ファーマスーティカルズ・エルエルシー インフルエンザウイルス感染症の治療方法
US20070212331A1 (en) * 2006-03-07 2007-09-13 Baldassare Joseph J Methods and compositions for selectively killing cells
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
CN101547689B (zh) * 2006-10-02 2014-02-26 埃里莫斯医药品有限公司 通过醚键和氨基甲酸酯键四取代的ndga衍生物、它们的合成方法和药学用途
US8153171B1 (en) * 2007-10-02 2012-04-10 Allen Jay Cohen Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions
US7597914B1 (en) * 2007-10-02 2009-10-06 Allen Jay Cohen Ala-septic pre-cancerous liquid dissolving solution and method
CA2730265C (en) 2008-07-21 2016-06-28 Unigen, Inc. Series of skin-whitening (lightening) compounds
CN103492353A (zh) 2011-03-24 2014-01-01 尤尼根公司 用于制备二芳基丙烷的化合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404146A (en) * 1980-12-17 1983-09-13 Biosystems Research Inc. Metal oxyalkylates and method of making same
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6330486A (en) * 1986-08-25 1988-03-24 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6737987A (en) * 1986-11-19 1988-06-16 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
WO1988003026A1 (en) 1988-05-05
AU616641B2 (en) 1991-11-07
JPH01501794A (ja) 1989-06-22
US4880637A (en) 1989-11-14
KR880701556A (ko) 1988-11-03
EP0288534B1 (de) 1991-12-18
ATE70449T1 (de) 1992-01-15
EP0288534A4 (de) 1989-02-23
EP0288534A1 (de) 1988-11-02
AU8172487A (en) 1988-05-25

Similar Documents

Publication Publication Date Title
DE3775387D1 (de) Zusammensetzungen von katecholischen butanen mit zink.
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
FI943445A0 (fi) Vesiliukoisten teksafyriinien metallikomplekseja
ES2059328T3 (es) Agentes para el tratamiento de artrosis.
DE3751361D1 (de) Verwendung von Hydroxycarbonsäuren zur Verstärkung der therapeutischen Effekte von topischen Zubereitungen gegen Pilzinfektionen und Pigmentflecken.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
AU8103782A (en) Aroylimidazolones
JPS57185208A (en) Skin cosmetic
FI820115L (fi) Tetrahydronaftalen- och indanfoereningar
DE3785046A1 (de)
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
SE8703210L (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ATE111348T1 (de) Kosmetische zusammensetzung auf der basis von chromo-carboxylaten.
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
KR870003788A (ko) 모발자극 화합물
JPS5748915A (en) Tumor inhibiting pharmaceutical composition and use thereof
BR7506930A (pt) Composto selecionado dentre compostos de 1 ariloxi-4-amino-2-butanol,composicao farmaceutica tendo atividade inibitoria de arritmia,processo de inibicao de arritmia cardiaca,e composto selecionado dentre os compostos de 1-ariloxi-4-cloro-2-butanol
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
ATE82113T1 (de) Topische zusammensetzungen.
IT8520282A0 (it) Procedimento per migliorare le proprieta' del cemento, e cemento cosi' ottenuto.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee